Codes / ICD10CM / D81.81

D81.81 Biotin-dependent carboxylase deficiency

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Biotin-dependent carboxylase deficiency

Summary

Biotin-dependent carboxylase deficiency is a rare inherited metabolic disorder that impairs the body's ability to utilize biotin, an essential B-vitamin, for normal metabolic processes. This condition disrupts the function of multiple carboxylase enzymes, which are critical for the metabolism of fats, proteins, and carbohydrates, leading to systemic biochemical imbalances.

Causes

This disorder is caused by genetic mutations that affect enzymes involved in biotin metabolism, such as biotinidase or holocarboxylase synthetase. These mutations reduce the body's ability to recycle or activate biotin, resulting in insufficient enzyme activity and impaired metabolic pathways.

Risk Factors

  • Genetic predisposition, typically inherited in an autosomal recessive pattern.
  • Family history of biotin-dependent metabolic disorders.
  • Consanguinity (parents who are closely related) may increase the risk of autosomal recessive forms.

Symptoms

  • Developmental delay or regression.
  • Hypotonia (decreased muscle tone).
  • Seizures or neurological abnormalities.
  • Skin rash, alopecia (hair loss), or dermatitis.
  • Metabolic acidosis or ketosis.
  • Respiratory distress or infections.

Diagnosis

Diagnosis involves biochemical testing to measure enzyme activity (e.g., biotinidase or holocarboxylase synthetase levels) and genetic testing to confirm pathogenic mutations. Newborn screening may detect the condition in some regions, and clinical evaluation of symptoms often guides further testing.

Treatment Options

  • High-dose biotin supplementation to restore enzyme function and correct metabolic imbalances.
  • Dietary management to support overall nutritional status.
  • Symptomatic treatment for complications (e.g., anticonvulsants for seizures).

Prognosis and Follow-Up

With early diagnosis and consistent biotin supplementation, many individuals can achieve stable metabolic control and avoid severe complications. Lifelong treatment is typically required, and regular follow-up monitoring of biochemical markers and clinical status is essential to adjust therapy as needed.

Complications

  • Untreated or delayed treatment may lead to irreversible neurological damage.
  • Severe metabolic crises, including acidosis or organ dysfunction.
  • Developmental disabilities or growth failure if not managed promptly.

Lifestyle & Prevention

  • Adherence to prescribed biotin supplementation is critical to prevent symptom recurrence.
  • Avoiding triggers (e.g., fasting or illness) that may exacerbate metabolic imbalances.
  • Genetic counseling for families to understand inheritance risks and reproductive options.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as seizures, severe lethargy, or respiratory distress occur, as these may indicate a metabolic crisis requiring urgent intervention.

Tips for Medical Coders

Document the specific enzyme deficiency (e.g., biotinidase or holocarboxylase synthetase) and any associated clinical manifestations to support accurate coding. Ensure documentation reflects the underlying metabolic disorder and its impact on patient care.

Book a walkthrough

D81.81 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.